Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	23,018	21,655	17,958	9,842	16,456
Depreciation & Amortization	3,683	3,438	2,860	2,986	2,936
Other Amortization	137.8	133.4	133.5	118.1	103.7
Loss (Gain) From Sale of Assets	-127.8	-46	31.8	123.6	14.3
Asset Writedown & Restructuring Costs	-	137.3	992.2	1,052	11.2
Loss (Gain) From Sale of Investments	-537.8	-528.9	-151.7	-308.6	35.2
Stock-Based Compensation	48.7	166.1	189.4	-	-
Provision & Write-off of Bad Debts	737.7	133.7	524	48.8	27.8
Other Operating Activities	-3,177	-3,821	-2,539	-303.9	-3,025
Change in Accounts Receivable	-3,289	-2,186	-2,220	-1,347	-2,218
Change in Inventory	-2,473	-2,612	-734	4,734	-6,731
Change in Accounts Payable	1,214	2,167	5,253	145.1	3,345
Change in Other Net Operating Assets	395.9	491.6	-2,816	-264.4	154.4
Operating Cash Flow	19,630	19,128	19,481	16,825	11,110
Operating Cash Flow Growth	2.62%	-1.81%	15.78%	51.44%	-12.16%

Investing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-6,173	-6,756	-2,593	-2,329	-3,389
Sale of Property, Plant & Equipment	1,303	408.4	724.8	32	109
Cash Acquisitions	-2,054	-	-	-	-
Investment in Securities	-13,025	-10,119	-10,612	1,955	-12,051
Other Investing Activities	3,277	3,479	2,395	1,471	979.6
Investing Cash Flow	-16,672	-12,988	-10,085	1,128	-14,351

Financing Activities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Short-Term Debt Issued	1,345	-	-	-	8,821
Long-Term Debt Issued	1,795	2,879	400	-	-
Total Debt Issued	3,140	2,879	400	-	8,821
Short-Term Debt Repaid	-	-4,820	-5,209	-12,690	-
Long-Term Debt Repaid	-1,064	-316.5	-323.2	-333.4	-404.6
Total Debt Repaid	-1,064	-5,137	-5,532	-13,023	-404.6
Net Debt Issued (Repaid)	2,076	-2,258	-5,132	-13,023	8,416
Common Dividends Paid	-6,098	-5,022	-5,380	-2,272	-4,185
Other Financing Activities	-1,012	-830.6	-937.6	675.9	-435.6
Financing Cash Flow	-5,034	-8,110	-11,450	-17,608	3,796

Net Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Foreign Exchange Rate Adjustments	-144.6	105.1	-20.5	71	25
Net Cash Flow	-2,220	-1,864	-2,075	416.2	579.6

Free Cash Flow

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	13,458	12,372	16,888	14,496	7,721
Free Cash Flow Growth	8.77%	-26.74%	16.50%	87.74%	-27.84%
Free Cash Flow Margin	9.15%	9.54%	13.33%	12.50%	7.26%
Free Cash Flow Per Share	112.56	103.48	141.24	121.24	64.58
Levered Free Cash Flow	7,669	7,779	26,299	5,554	-6,087
Unlevered Free Cash Flow	8,548	8,434	26,905	6,059	-5,894

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	1,235	806.1	913.1	904.6	401.3
Cash Income Tax Paid	6,290	5,040	4,069	2,734	3,969
Change in Working Capital	-4,152	-2,140	-516.9	3,268	-5,450

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 30, 2026

Data Sources Report a data error